InvestorsHub on MSN

Terns Pharma stock jumps on report of potential $6B takeover by Merck

Terns Pharmaceuticals (NASDAQ:TERN) shares surged in premarket trading after a report indicated that Merck & Company ...
BioPharma Dive

Merck’s deal for Terns sparks debate over a possible biotech bidding war

Some investors and analysts believe the pharma’s $6.7 billion offer is justified given Terns’ recent stock run. Others are ...
Zacks Investment Research on MSN

Merck stock soars 50% in 6 months: Buy, hold, or take profits?

Merck’s MRK stock has risen 51.4% in the past six months. A key driver of the increase is Merck’s improved outlook for ...
Fierce Biotech

Merck, girding for Keytruda cliff, flies toward promising CML asset with $6.7B Terns acquisition

Merck and Terns Pharmaceuticals have agreed to a $6.7 billion all-cash buyout that delivers a prized leukemia asset to the ...

Here’s Why Merck (MRK) Surged in Q4

Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Value Fund” ...
Forbes

Is Merck Stock’s Run Legitimate?

Merck (MRK) stock achieved a 5-day winning streak, with total gains during this time reaching 6.9%. The company’s market capitalization has jumped by approximately $17 billion over the past five ...